New drug could treat Alzheimer's, multiple sclerosis and brain injury
A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic ...
Neuroscience
Jul 24, 2012 |
4.9 / 5 (8) |
4
|
In reversing motor nerve damage, time is of the essence
When a motor nerve is severely damaged, people rarely recover full muscle strength and function. Neuroscientists from Children's Hospital Boston, combining patient data with observations in a mouse model, now show why. It's ...
Medical research
Oct 03, 2011 |
5 / 5 (3) |
0
|
Cooling treatment for acute ischemic strokes shows promising preliminary results
(Medical Xpress)—A limited time window to administer therapy for ischemic stroke means every second counts. Now doctors may be able to slow down the hands of time in this critical time frame by using hypothermia ...
Cardiology
Feb 21, 2013 |
not rated yet |
0
New method is first to predict brain cancer outcome and quickly show if therapy is effective
The critical question shortly after a brain cancer patient starts treatment: how well is it working? But there hasn't been a good way to gauge that.
Cancer
Jan 23, 2013 |
not rated yet |
0
|
Delay in breaking up blood clots means worse stroke outcome
Every 30-minute delay in breaking up a blood clot from a stroke was associated with a 10 percent decrease in the probability of a good outcome, regardless of other factors such as stroke severity, according ...
Cardiology
Feb 11, 2013 |
not rated yet |
0
Therapeutic time window important factor for cord blood cell transplantation after stoke
A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within ...
Medical research
Oct 01, 2012 |
not rated yet |
0
Study: Antiretroviral therapy for HIV-1 in first four months is crucial
Patients who are started on antiretroviral therapy for HIV-1 infection within four months of estimated infection date—and who have higher counts of CD4+ T-cells at the initiation of therapy—demonstrate a stronger recovery ...
HIV & AIDS
Jan 16, 2013 |
not rated yet |
0
|
Hypothermia protects the brain against damage during stroke
Thromboembolic stroke, caused by a blood clot in the brain, results in damage to the parts of the brain starved of oxygen. Breaking up the clot with tissue plasminogen activator (tPA) reduces the amount of damage, however, ...
Neuroscience
Mar 06, 2012 |
5 / 5 (1) |
0
Adding endovascular therapy to tPA didn't improve recovery after stroke
Adding endovascular therapy to clot-busting therapy for stroke did not significantly improve stroke recovery at three months, according to a study presented in a special symposium at the American Stroke Association's International ...
Cardiology
Feb 08, 2013 |
not rated yet |
0
Mayo Clinic maps brain, finds Alzheimer's patients drive differently
Activity lingers longer in certain areas of the brain in those with Alzheimer's than it does in healthy people, Mayo Clinic researchers who created a map of the brain found. The results suggest varying brain activity may ...
Alzheimer's disease & dementia
Jul 16, 2012 |
not rated yet |
0
|
U.s. underestimates long-term costs of obesity, experts say
(HealthDay) -- The costs of the obesity epidemic to the United States and the economic value of curbing it are not captured fully by current methods, according to a new report.
Health
Mar 21, 2012 |
5 / 5 (1) |
0
Stroke blood test that could increase use of most effective treatment five-fold
Researchers at the University of Geneva (UNIGE), in collaboration with UK company Proteome Sciences plc (PS) describe a simple blood test that could substantially increase the number of patients eligible for highly effective ...
Cardiology
Sep 20, 2012 |
5 / 5 (1) |
0
